Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-21-064771

Options or other derivatives

  • Director acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Hunter C · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-12 Grant or award : show line 1 in the form Director Stock Option (right to buy) +60,000 60,000 D
Loading xslF345X03/doc4.xml…